ALTERED PEPTIDE LIGANDS CAN CONTROL CD4 T-LYMPHOCYTE DIFFERENTIATION IN-VIVO

被引:361
|
作者
PFEIFFER, C
STEIN, J
SOUTHWOOD, S
KETELAAR, H
SETTE, A
BOTTOMLY, K
机构
[1] YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520
[2] HOWARD HUGHES MED INST,NEW HAVEN,CT 06520
[3] CYTEL CORP,SAN DIEGO,CA 92121
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 181卷 / 04期
关键词
D O I
10.1084/jem.181.4.1569
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antigen priming of naive CD4 T cells can generate effector CD4 T cells that produce interleukin 4 (T helper [Th]2-like) or interferon-gamma (Th1-like). Using a system in which priming leads to responses dominated by one or the other of these cell types, we show that varying either the antigenic peptide or the major histocompatibility complex class II molecule can determine whether Th1-like or Th2-like responses are obtained. Our results show that peptide/major histocompatibility complex class II complexes that interact strongly with the T cell receptor favor generation of Th1-like cells, while those that bind weakly favor priming of Th2-like T cells. Thus, signals from the T cell receptor can influence the differentiation of CD4 T cells into specific types of effector cells.
引用
收藏
页码:1569 / 1574
页数:6
相关论文
共 50 条
  • [21] Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy
    Bennett, KK
    DeGruttola, VG
    Marschner, IC
    Havlir, DV
    Richman, DD
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (01) : 20 - 26
  • [22] Pattern of CD4 T-lymphocyte Values in Cancer Patients on Cytotoxic Therapy
    Madu, A. J.
    Ocheni, S.
    Ibegbulam, O. G.
    Aguwa, E. N.
    Madu, K. A.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2013, 3 (04) : 498 - 503
  • [23] THE MAIN INFILTRATING CELL IN XENOGRAFT REJECTION IS A CD4(+) MACROPHAGE AND NOT A T-LYMPHOCYTE
    WALLGREN, AC
    KARLSSONPARRA, A
    KORSGREN, O
    TRANSPLANTATION, 1995, 60 (06) : 594 - 601
  • [24] Establishment of reference range of CD4 T-lymphocyte in healthy Nepalese adults
    Mishra, Shravan Kumar
    Shrestha, Lilee
    Pandit, Roshan
    Khadka, Sundar
    Shrestha, Bimal
    Dhital, Subhash
    Sharma, Saroj
    Sharma, Mukunda
    Mahato, Raj Kumar
    Shakya, Geeta
    Das Manandhar, Krishna
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [25] CD4 CYTO-TOXIC LYMPHOCYTE-T DIFFERENTIATION
    BENSUSSAN, A
    BIOCHIMIE, 1988, 70 (07) : 937 - 941
  • [26] THE PATTERN OF T-LYMPHOCYTE DIFFERENTIATION IS ALTERED DURING THYMIC INVOLUTION
    THOMAN, ML
    MECHANISMS OF AGEING AND DEVELOPMENT, 1995, 82 (2-3) : 155 - 170
  • [27] Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation
    Fornara, Olesja
    Odeberg, Jenny
    Khan, Zahidul
    Stragliotto, Giuseppe
    Peredo, Inti
    Butler, Lynn
    Soderberg-Naucler, Cecilia
    IMMUNOBIOLOGY, 2013, 218 (08) : 1034 - 1040
  • [28] CAN T-LYMPHOCYTE PROLIFERATION AID THE PROGNOSTIC VALUE OF CD4 LEVELS IN TREATMENT DECISIONS IN HIV INFECTED HEMOPHILIACS
    EVANS, JA
    PASI, KJ
    HILL, FGH
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1163 - 1163
  • [29] A simplified CD4 T-lymphocyte cell count in patients with HIV AIDS in Mexico
    Guarner, J
    SanchezMejoradaFernandez, G
    delRioChiriboga, C
    Mohar, A
    SALUD PUBLICA DE MEXICO, 1996, 38 (03): : 207 - 211
  • [30] POLYCLONAL AND CLONAL ANALYSIS OF HUMAN CD4(+) T-LYMPHOCYTE RESPONSES TO NUT EXTRACTS
    HIGGINS, JA
    LAMB, JR
    LAKE, RA
    OHEHIR, RE
    IMMUNOLOGY, 1995, 84 (01) : 91 - 97